Publications by authors named "S S Lathrop"

The National Center for Biotechnology Information (NCBI) provides online information resources for biology, including the GenBank® nucleic acid sequence repository and the PubMed® repository of citations and abstracts published in life science journals. NCBI provides search and retrieval operations for most of these data from 31 distinct repositories and knowledgebases. The E-utilities serve as the programming interface for most of these.

View Article and Find Full Text PDF

Shigellosis is a gastrointestinal infection caused by species of . A large outbreak of serotype 2a occurred in Albuquerque, New Mexico (NM) between May 2021 and November 2023 that involved humans and nonhuman primates (NHP) from a local zoo. We analyzed the genomes of 202 New Mexico isolates as well as 15 closely related isolates from other states, and four from NHP.

View Article and Find Full Text PDF

Reducing foodborne disease incidence is a public health priority. This report summarizes preliminary 2023 Foodborne Diseases Active Surveillance Network (FoodNet) data and highlights efforts to increase the representativeness of FoodNet. During 2023, incidences of domestically acquired campylobacteriosis, Shiga toxin-producing Escherichia coli infection, yersiniosis, vibriosis, and cyclosporiasis increased, whereas those of listeriosis, salmonellosis, and shigellosis remained stable compared with incidences during 2016-2018, the baseline used for tracking progress towards federal disease reduction goals.

View Article and Find Full Text PDF

Background: In the US, yersinosis was understood to predominantly occur in winter and among Black or African American infants and Asian children. Increased use of culture-independent diagnostic tests (CIDTs) has led to marked increases in yersinosis diagnoses.

Methods: We describe differences in the epidemiology of yersiniosis diagnosed by CIDT versus culture in 10 US sites, and identify determinants of health associated with diagnostic method.

View Article and Find Full Text PDF
Article Synopsis
  • Despite vaccines against COVID-19, SARS-CoV-2 continues to spread, prompting the need for new vaccines with better effectiveness.
  • Researchers developed an adjuvanted subunit vaccine using the receptor-binding domain (RBD) of the virus's spike protein and synthetic adjuvants to enhance immune response.
  • Their findings show that adding specific TLR (toll-like receptor) ligands improves immune response types and boosts antibody production against SARS-CoV-2.
View Article and Find Full Text PDF